Evaluate report signals orphan drug market is niche no more
London, UK – 28 April 2022 – Evaluate, the leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today released the findings of its 2022 Orphan Drug Report. Evaluate’s data shows […]